Skip to main content
Key Specialties
Anesthesiology Cardiology Dermatology Diabetology Endocrinology Gastroenterology General Medicine Geriatrics Hematology Infectious Diseases Internal Medicine Nephrology Neurology Obstetrics and Gynecology Oncology Ophthalmology Pediatrics Psychiatry Radiology Respiratory Medicine Rheumatology Surgery Urology
Congress Coverage
ASH 2024 Annual Meeting 2024 ESMO Congress 2024 ERS Congress 2024 EASD Congress 2024 ESC Congress 2024 EAN Congress 2024 ASCO Annual Meeting 2024 ACC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on adolescent vaping

LIVE: Wednesday 29th January, 18:00-19:30 CET

Growing numbers of young people are using e-cigarettes, despite warnings of respiratory effects and addiction. How can doctors tackle the epidemic, and what health effects should you prepare to manage in your clinics?
ADVANCED SEARCH
Log in
Top
Journal of Diabetes & Metabolic Disorders
Published in:

Open Access 01-12-2017 | Review article

Salivary glucose in monitoring glycaemia in patients with type 1 diabetes mellitus: a systematic review

Authors: Cho Naing, Joon Wah Mak

Published in: Journal of Diabetes & Metabolic Disorders | Issue 1/2017

Login to get access

Abstract

Background

Incidence of type 1 diabetes mellitus is increasing worldwide. Monitoring glycaemia is essential for control of diabetes mellitus. Conventional blood-based measurement of glucose requires venepuncture or needle prick, which is not free from pain and risk of infection. The non-invasiveness, ease and low-cost in collection made saliva an attractive alternative sample. The objective of this review was to systematically review the evidence on the relationship between salivary glucose level and blood glucose level in monitoring glycaemia in patients with type 1 diabetes mellitus.

Methods

We searched studies which evaluate salivary glucose levels and serum glycaemia in type 1 diabetes mellitus in electronic databases of MEDLINE, EMBASE, Ovid and Google Scholar. We selected the eligible studies, following the inclusion criteria set for this review. Due to heterogeneity of studies, we conducted qualitative synthesis of studies.

Results

Ten observational studies were included in this review, including a total of 321 cases and 323 controls with ages between 3 and 61 years and the majority were males (62%). Two studies were done exclusively on children below 17 years old. The significant difference between salivary glucose levels in type 1 diabetes mellitus and controls were reported in 6 studies with 8 data sets. Five studies with 7 datasets reported the correlation coefficient between salivary glucose and blood glucose in patients with diabetes.

Conclusions

Findings suggest that salivary glucose concentrations may be helpful in monitoring glycaemia in type 1 diabetes mellitus. However, the utility of using salivary glucose level to monitor glycaemia should be evaluated in future well designed, prospective studies with adequate number of participants with type 1 diabetes mellitus.
Appendix
Available only for authorised users
Literature
1.
2.
3.
Patterson CC, Dahlquist GG, Gyurus E, Green A, Soltesz G. Incidence trends for childhood type 1 diabetes in Europe during 1989–2003 and predicted new cases 2005–20: a multicentre prospective registration study. Lancet. 2009;373:2027–33.CrossRefPubMed
4.
Simmons JH, et al. Reliability of the diabetes fear of injecting and self-testing questionnaire in paediatric patients with type 1 diabetes. Diabetes Care. 2007;30:987–8.CrossRefPubMed
5.
Wright S, Yelland M, Heathcote K, Ng SK, Wright G. Fear of needles—nature and prevalence in general practice. Aust Fam Physician. 2009;38:172–6.PubMed
6.
Chiasson JL, Morrisset R, Hamet P. Precision and costs of techniques for self-monitoring of serum glucose levels. Can Med Assoc J. 1984;130:38–43.PubMedPubMedCentral
7.
Soukup M, Biesiada I, Henderson A, Idowu B, Rodeback D, Ridpath L, Bridges EG, Nazar AM, Bridges KG. Salivary uric acid as a noninvasive biomarker of metabolic syndrome. Diabetol Metab Syndr. 2012;4:14.CrossRefPubMedPubMedCentral
8.
Raggam RB, Wagner J, Michelin BDA, Putz-Bankuti C, et al. Reliable detection and quantitation of viral nucleic acids in oral fluid: liquid phase-based sample collection in conjunction with automated and standardized molecular assays. J Med Virol. 2008;80:1684–8.CrossRefPubMed
9.
Rathnayake N, Åkerman S, Klinge B, Lundegren N, Jansson H, Tryselius Y, et al. Salivary biomarkers for detection of systemic diseases. PLoS One. 2013;8(4):e61356.CrossRefPubMedPubMedCentral
10.
Lopez ME, Colloca ME, Paez RG, Schallmach JN, Koss MA, Chervonagura A. Salivary characteristics of diabetic children. Braz Dent J. 2003;14:26–31.CrossRefPubMed
11.
Amer S, Yousuf M, Siddqiui PQ, Alam J. Salivary glucose concentrations in patients with diabetes mellitus—a minimally invasive technique for monitoring blood glucose levels. Pak J Pharm Sci. 2001;14:33–7.PubMed
12.
Vaziri PB, Vahedi M, Mortazavi H, Abdollahzadeh S, Hajilooi M. Evaluation of salivary glucose, IgA and flow rate in diabetic patients: a case-control study. J Dent (Tehran). 2010;7:13–8.
13.
Mascarenhas P, Fatela B, Barahona I. Effect of diabetes mellitus type 2 on salivary glucose — a systematic review and meta-analysis of observational studies. PLoS One. 2014;9:e101706.CrossRefPubMedPubMedCentral
14.
Al-Tarawneh SK, Border BM, Dibble FC, Bencharit S. Defining salivary biomarkers using mass spectrometry-based proteomics: a systematic review. OMICS. 2011;15:353–61.CrossRefPubMedPubMedCentral
15.
Nunes LAS, Mussavira S, Bindhu OS. Clinical and diagnostic utility of saliva as a non-invasive diagnostic fluid: a systematic review. Biochem Med (Zagreb). 2015;25:177–92.CrossRef
16.
Bertoluci MC, Ce GV, da Silva AM, Wainstein MV, Boff W, Punales M. Endothelial dysfunction as a predictor of cardiovascular disease in type 1 diabetes. World J Diabetes. 2015;6:679–92.CrossRefPubMedPubMedCentral
17.
Moher D, Liberati A, Tetzlaff J, Altman DG, Group PRISMA. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6.
18.
19.
20.
Borenstein M, Hedges VL, Higgins PTJ, Rothstein RH. Introduction to meta-analysis. West Sussex, UK: John Wiley and Sons Ltd; 2009.CrossRef
21.
22.
23.
24.
Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration; 2011. www.​cochranehandbook​.​org. Accessed 4 Jan 2016.
25.
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700
26.
Harrison R, Bowen WH. Flow rate and organic constituents of whole saliva in insulin-dependent diabetic children and adolescents. Pediatr Dent. 1987;9:287–91.PubMed
27.
Darwazeh AM, MacFarlane TW, McCuish A, Lamey PJ. Mixed salivary glucose levels and candidal carriage in patients with diabetes mellitus. J Oral Pathol Med. 1991;20:280–3.CrossRefPubMed
28.
Andersson BA, Birkhed D, Berntorp K, Lindgarde F, Matsson L. Glucose concentration in parotid saliva after glucose/food intake in individuals with glucose intolerance and diabetes mellitus. Eur J Oral Sci. 1998;106:931–7.CrossRef
29.
Belazi MA, Galli-Tsinopoulou A, Drakoulakos D, Fleva A, Papanayiotou PH. Salivary alterations in insulin-dependent diabetes mellitus. Int J Paediatr Dent. 1998;8:29–33.CrossRefPubMed
30.
Panchbhai AS, Degwekar SS, Bhowte RR, Degweka SS. Estimation of salivary glucose, salivary amylase, salivary total protein and salivary flow rate in diabetics in India. J Oral Sci. 2010;52:359–68.CrossRefPubMed
31.
Nagalaxmi V, Priyanka V. Can saliva be a marker for predicting type 1 diabetes mellitus?—a pilot study. J Indian Acad Oral Med Radiol. 2011;23:579–82.CrossRef
32.
Behal S, Lele S. Correlation of salivary glucose with blood glucose in diabetic individuals. Indian J Stomatol. 2012;3:212–6.
33.
34.
Mata AD, Marques D, Rocha S, et al. Effects of diabetes mellitus on salivary secretion and its composition in the human. Mol Cell Biochem. 2004;261:137–42.CrossRefPubMed
35.
36.
Abikshyeet P, Ramesh V, Oza V. Glucose estimation in the salivary secretion of diabetes mellitus patients. Diabetes Metab Syndr Obes Targets Ther. 2012;5:149–54.
37.
Jurysta C, Bulur N, Oguzhan B et al. Salivary glucose concentration and excretion in normal and diabetic subjects. J Biomed Biotechnol. 2009;6.
38.
Lasisi TJ, Fasanmade AA. Salivary flow and composition in diabetic and non-diabetic subjects. Niger J Physiol Sci. 2012;27:79–82.PubMed
39.
Barnes MV, Kennedy DA, Panagakos F et al. Global metabolomic analysis of human saliva and plasma from healthy and diabetic subjects, with and without periodontal disease. PLoS One. 2014;9:e105181. Correction in: PLoS One 9: e114091.
40.
Forbat LN, Collins RE, Maskell GK, Sonksen PH. Glucose concentrations in parotid fluid and venous blood of patients attending a diabetic clinic. J R Soc Med. 1981;74:725–8.PubMedPubMedCentral
41.
Sandberg GE, Sundberg HE, Fjellstrom CA, Wikblad KF. Type 2 diabetes and oral health: a comparison between diabetic and non-diabetic subjects. Diabetes Res Clin Pract. 2000;50:27–34.CrossRefPubMed
42.
43.
Vasconcelos ACU, Soares MSM, Almeida PC, Soares TC. Comparative study of the concentration of salivary and blood glucose in type 2 diabetic patients. J Oral Sci. 2010;52:293–8.CrossRefPubMed
44.
Moore PA, Weyant RJ, Etzel KR, et al. Type 1 diabetes mellitus and oral health: assessment of coronal and root caries. Community Dent Oral Epidemiol. 2001;29:183–94.CrossRefPubMed
45.
Moreira AR, Passos IA, Sampaio FC, Soares MS, Oliveira RJ. Flow rate, pH and calcium concentration of saliva of children and adolescents with type 1 diabetes mellitus. Braz J Med Biol Res. 2009;42:707–11.CrossRefPubMed
46.
Collin HL, Uusitupa M, Niskanen L, Koivisto AM, Markkanen H, Meurman JH. Caries in patients with non-insulin-dependent diabetes mellitus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1988;85:680–5.CrossRef
47.
48.
Chatterton Jr RT, Vogelsong KM, Lu YC, Ellman AB, Hudgens GA. Salivary alpha-amylase as a measure of endogenous adrenergic activity. Clin Physiol. 1996;16:433–48.CrossRefPubMed
49.
Karjalainen KM, Knuuttila ML, Kaar ML. Salivary factors in children and adolescents with insulin-dependent diabetes mellitus. Pediatr Dent. 1996;18:306–11.PubMed
Metadata
Title
Salivary glucose in monitoring glycaemia in patients with type 1 diabetes mellitus: a systematic review
Authors
Cho Naing
Joon Wah Mak
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Journal of Diabetes & Metabolic Disorders / Issue 1/2017
Electronic ISSN: 2251-6581
DOI
https://doi.org/10.1186/s40200-017-0287-5

Other articles of this Issue 1/2017

Assessment of analytical performance of glucose meter in pediatric age group at tertiary care referral hospital

  • Open Access
  • Research article

Smart article: application of intelligent platforms in next generation biomedical publications

  • Open Access
  • Letter to the Editor

Technical efficiency of rural primary health care system for diabetes treatment in Iran: a stochastic frontier analysis

  • Open Access
  • Research article

National action plan for non-communicable diseases prevention and control in Iran; a response to emerging epidemic

  • Open Access
  • Review article

The effect of cardamom supplementation on serum lipids, glycemic indices and blood pressure in overweight and obese pre-diabetic women: a randomized controlled trial

  • Open Access
  • Research article

Glucose variability for cardiovascular risk factors in type 2 diabetes: a meta-analysis

  • Open Access
  • Review article

Keynote webinar | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the broader systemic effects of menopause, so you can help patients in your clinics through the transition.   

Prof. Martha Hickey
Dr. Claudia Barth
Dr. Samar El Khoudary
Developed by: Springer Medicine
Watch now

Keynote webinar | Spotlight on adolescent vaping

  • Live
  • Webinar | 29-01-2025 | 18:00 (CET)

Growing numbers of young people are using e-cigarettes, despite warnings of respiratory effects and addiction. How can doctors tackle the epidemic, and what health effects should you prepare to manage in your clinics?

Watch it live: Wednesday 29th January, 18:00-19:30 CET
 

Prof. Ann McNeill
Dr. Debbie Robson
Benji Horwell
Developed by: Springer Medicine
Join the webinar

Keynote webinar | Spotlight on modern management of frailty

Frailty has a significant impact on health and wellbeing, especially in older adults. Our experts explain the factors that contribute to the development of frailty and how you can manage the condition and reduce the risk of disability, dependency, and mortality in your patients.

Prof. Alfonso Cruz-Jentoft
Prof. Barbara C. van Munster
Prof. Mirko Petrovic
Developed by: Springer Medicine
Watch now

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Read more
Image Credits